T1	NC 0 6	Hombre
#1	Norm T1	hombre NCMS000
T2	SP 7 9	de
#2	Norm T2	de SPS00
T3	Z 10 12	39
#3	Norm T3	39 Z
T4	NC 13 17	años
#4	Norm T4	año NCMP000
T5	SP 18 21	sin
#5	Norm T5	sin SPS00
T6	NC 22 29	hábitos
#6	Norm T6	hábito NCMP000
T7	AQ 30 37	tóxicos
#7	Norm T7	tóxico AQ0MP0
T8	Fc 37 38	,
#8	Norm T8	, Fc
T9	AQ 39 47	alérgico
#9	Norm T9	alérgico AQ0MS0
T10	SP 48 50	al
#10	Norm T10	a+el SPS00+DA0MS0
T11	NC 51 56	ácido
#11	Norm T11	ácido NCMS000
T12	AQ 57 73	acetilsalicílico
#12	Norm T12	acetilsalicílico AQ0MS0
T13	Fpa 74 75	(
#13	Norm T13	( Fpa
T14	NC 75 78	AAS
#14	Norm T14	AAS NC00000
T15	Fpt 78 79	)
#15	Norm T15	) Fpt
T16	CC 80 81	y
#16	Norm T16	y CC
T17	SP 82 84	al
#17	Norm T17	a+el SPS00+DA0MS0
T18	NC 85 96	diclofenaco
#18	Norm T18	diclofenaco NCMS000
T19	Fp 96 97	.
#19	Norm T19	. Fp
T20	VM 98 106	Consulta
#20	Norm T20	consultar VMIP3S0
T21	RG 107 119	inicialmente
#21	Norm T21	inicialmente RG
T22	SP 120 123	por
#22	Norm T22	por SPS00
T23	NC 124 135	tumefacción
#23	Norm T23	tumefacción NCFS000
T24	SP 136 138	de
#24	Norm T24	de SPS00
T25	NC 139 145	partes
#25	Norm T25	parte NCFP000
T26	AQ 146 153	blandas
#26	Norm T26	blando AQ0FP0
T27	VM 154 162	asociada
#27	Norm T27	asociar VMP00SF
T28	SP 163 164	a
#28	Norm T28	a SPS00
T29	NC 165 172	púrpura
#29	Norm T29	púrpura NCMS000
T30	AQ 173 181	palpable
#30	Norm T30	palpable AQ0CS0
T31	SP 182 184	en
#31	Norm T31	en SPS00
T32	DI 185 190	ambas
#32	Norm T32	ambos DI0FP0
T33	NC 191 203	extremidades
#33	Norm T33	extremidad NCFP000
T34	AQ 204 214	inferiores
#34	Norm T34	inferior AQ0CP0
T35	SP 215 217	en
#35	Norm T35	en SPS00
T36	NC 218 223	abril
#36	Norm T36	abril NCMS000
T37	SP 224 226	de
#37	Norm T37	de SPS00
T38	Z 227 231	2001
#38	Norm T38	2001 Z
T39	Fp 231 232	.
#39	Norm T39	. Fp
T40	P0 233 235	Se
#40	Norm T40	se P00CN000
T41	VM 236 243	realizó
#41	Norm T41	realizar VMIS3S0
T42	NC 244 251	estudio
#42	Norm T42	estudio NCMS000
T43	AQ 252 264	inmunológico
#43	Norm T43	inmunológico AQ0MS0
T44	PR 265 268	que
#44	Norm T44	que PR0CN000
T45	VM 269 273	puso
#45	Norm T45	poner VMIS3S0
T46	SP 274 276	de
#46	Norm T46	de SPS00
T47	AQ 277 287	manifiesto
#47	Norm T47	manifiesto AQ0MS0
T48	NC 288 304	crioglobulinemia
#48	Norm T48	crioglobulinemia NCFS000
T49	AQ 305 313	positiva
#49	Norm T49	positivo AQ0FS0
T50	SP 314 317	con
#50	Norm T50	con SPS00
T51	NC 318 327	criocrito
#51	Norm T51	criocrito NCMS000
T52	SP 328 330	de
#52	Norm T52	de SPS00
T53	Z 331 335	9,2%
#53	Norm T53	9,2% Z
T54	Fpa 336 337	(
#54	Norm T54	( Fpa
T55	NC 337 340	IgM
#55	Norm T55	igm NC00000
T56	NC 341 346	kappa
#56	Norm T56	kappa NCFS000
T57	SP 347 349	de
#57	Norm T57	de SPS00
T58	NC 350 358	carácter
#58	Norm T58	carácter NCMS000
T59	AQ 359 369	monoclonal
#59	Norm T59	monoclonal AQ0CS0
T60	CC 370 371	y
#60	Norm T60	y CC
T61	AQ 372 382	componente
#61	Norm T61	componente AQ0CS0
T62	NP 383 386	IgG
#62	Norm T62	igg NP00000
T63	Fpt 386 387	)
#63	Norm T63	) Fpt
T64	Fp 387 388	.
#64	Norm T64	. Fp
T65	DA 389 392	Las
#65	Norm T65	el DA0FP0
T66	NC 393 403	serologías
#66	Norm T66	serología NCFP000
T67	SP 404 408	para
#67	Norm T67	para SPS00
T68	NC 409 414	virus
#68	Norm T68	virus NCMN000
T69	NC 415 427	hepatotropos
#69	Norm T69	hepatotropo NCMP000
T70	CC 428 429	y
#70	Norm T70	y CC
T71	NC 430 435	virus
#71	Norm T71	virus NCMN000
T72	SP 436 438	de
#72	Norm T72	de SPS00
T73	DA 439 441	la
#73	Norm T73	el DA0FS0
T74	NC 442 459	inmunodeficiencia
#74	Norm T74	inmunodeficiencia NCFS000
T75	AQ 460 466	humana
#75	Norm T75	humano AQ0FS0
T76	Fpa 467 468	(
#76	Norm T76	( Fpa
T77	NC 468 471	VIH
#77	Norm T77	VIH NC00000
T78	Fpt 471 472	)
#78	Norm T78	) Fpt
T79	VS 473 479	fueron
#79	Norm T79	ser VSIS3P0
T80	AQ 480 489	negativas
#80	Norm T80	negativo AQ0FP0
T81	Fc 489 490	,
#81	Norm T81	, Fc
T82	RG 491 494	así
#82	Norm T82	así RG
T83	CS 495 499	como
#83	Norm T83	como CS
T84	RG 500 507	también
#84	Norm T84	también RG
T85	VM 508 514	dieron
#85	Norm T85	dar VMIS3P0
T86	AQ 515 524	negativos
#86	Norm T86	negativo AQ0MP0
T87	DA 525 528	los
#87	Norm T87	el DA0MP0
T88	NC 529 540	anticuerpos
#88	Norm T88	anticuerpo NCMP000
T89	AQ 541 559	antifosfolipídicos
#89	Norm T89	antifosfolipídico AQ0MP0
T90	Fp 559 560	.
#90	Norm T90	. Fp
T91	SP 561 563	En
#91	Norm T91	en SPS00
T92	DA 564 566	la
#92	Norm T92	el DA0FS0
T93	NC 567 578	exploración
#93	Norm T93	exploración NCFS000
T94	AQ 579 585	física
#94	Norm T94	físico AQ0FS0
T95	VM 586 595	destacaba
#95	Norm T95	destacar VMII3S0
T96	DA 596 598	la
#96	Norm T96	el DA0FS0
T97	NC 599 608	presencia
#97	Norm T97	presencia NCFS000
T98	SP 609 611	de
#98	Norm T98	de SPS00
T99	NC 612 619	púrpura
#99	Norm T99	púrpura NCMS000
T100	AQ 620 628	palpable
#100	Norm T100	palpable AQ0CS0
T101	SP 629 631	en
#101	Norm T101	en SPS00
T102	DA 632 635	las
#102	Norm T102	el DA0FP0
T103	NC 636 648	extremidades
#103	Norm T103	extremidad NCFP000
T104	AQ 649 659	inferiores
#104	Norm T104	inferior AQ0CP0
T105	Fx 659 660	;
#105	Norm T105	; Fx
T106	DA 661 663	el
#106	Norm T106	el DA0MS0
T107	NC 664 669	resto
#107	Norm T107	resto NCMS000
T108	SP 670 673	del
#108	Norm T108	de+el SPS00+DA0MS0
T109	NC 674 680	examen
#109	Norm T109	examen NCMS000
T110	VS 681 684	fue
#110	Norm T110	ser VSIS3S0
T111	AQ 685 692	anodino
#111	Norm T111	anodino AQ0MS0
T112	Fp 692 693	.
#112	Norm T112	. Fp
T113	P0 694 696	Se
#113	Norm T113	se P00CN000
T114	VM 697 704	realizó
#114	Norm T114	realizar VMIS3S0
T115	DI 705 708	una
#115	Norm T115	uno DI0FS0
T116	NC 709 719	tomografía
#116	Norm T116	tomografía NCFS000
T117	VM 720 733	computarizada
#117	Norm T117	computarizar VMP00SF
T118	Fpa 734 735	(
#118	Norm T118	( Fpa
T119	NC 735 737	TC
#119	Norm T119	TC NC00000
T120	Fpt 737 738	)
#120	Norm T120	) Fpt
T121	AQ 739 754	toracoabdominal
#121	Norm T121	toracoabdominal AQ0CS0
T122	SP 755 757	en
#122	Norm T122	en SPS00
T123	DA 758 760	la
#123	Norm T123	el DA0FS0
T124	PR 761 764	que
#124	Norm T124	que PR0CN000
T125	RN 765 767	no
#125	Norm T125	no RN
T126	P0 768 770	se
#126	Norm T126	se P00CN000
T127	VM 771 783	evidenciaron
#127	Norm T127	evidenciar VMIS3P0
T128	NC 784 795	adenopatías
#128	Norm T128	adenopatía NCFP000
T129	CC 796 798	ni
#129	Norm T129	ni CC
T130	NC 799 814	visceromegalias
#130	Norm T130	visceromegalia NCFP000
T131	Fp 814 815	.
#131	Norm T131	. Fp
T132	SP 816 819	Con
#132	Norm T132	con SPS00
T133	DA 820 822	la
#133	Norm T133	el DA0FS0
T134	NC 823 834	orientación
#134	Norm T134	orientación NCFS000
T135	SP 835 837	de
#135	Norm T135	de SPS00
T136	DI 838 841	una
#136	Norm T136	uno DI0FS0
T137	NC 842 852	vasculitis
#137	Norm T137	vasculitis NCFN000
T138	AQ 853 860	cutánea
#138	Norm T138	cutáneo AQ0FS0
T139	Fc 860 861	,
#139	Norm T139	, Fc
T140	P0 862 864	se
#140	Norm T140	se P00CN000
T141	VM 865 871	inició
#141	Norm T141	iniciar VMIS3S0
T142	NC 872 883	tratamiento
#142	Norm T142	tratamiento NCMS000
T143	SP 884 887	con
#143	Norm T143	con SPS00
T144	NC 888 898	prednisona
#144	Norm T144	prednisona NCFS000
T145	SP 899 900	a
#145	Norm T145	a SPS00
T146	NC 901 906	dosis
#146	Norm T146	dosis NCFN000
T147	SP 907 909	de
#147	Norm T147	de SPS00
T148	Z 910 911	1
#148	Norm T148	1 Z
T149	NC 912 914	mg
#149	Norm T149	mg NC00000
T150	Fh 914 915	/
#150	Norm T150	/ Fh
T151	NC 915 917	kg
#151	Norm T151	kg NC00000
T152	Fh 917 918	/
#152	Norm T152	/ Fh
T153	NC 918 921	día
#153	Norm T153	día NCMS000
T154	Fc 921 922	,
#154	Norm T154	, Fc
T155	SP 923 926	con
#155	Norm T155	con SPS00
T156	DI 927 930	una
#156	Norm T156	uno DI0FS0
T157	NC 931 940	evolución
#157	Norm T157	evolución NCFS000
T158	AQ 941 948	inicial
#158	Norm T158	inicial AQ0CS0
T159	AQ 949 958	favorable
#159	Norm T159	favorable AQ0CS0
T160	CC 959 960	y
#160	Norm T160	y CC
T161	DA 961 963	la
#161	Norm T161	el DA0FS0
T162	NC 964 976	desaparición
#162	Norm T162	desaparición NCFS000
T163	SP 977 979	de
#163	Norm T163	de SPS00
T164	DA 980 983	las
#164	Norm T164	el DA0FP0
T165	NC 984 992	lesiones
#165	Norm T165	lesión NCFP000
T166	Fp 992 993	.
#166	Norm T166	. Fp
T167	DI 994 996	Un
#167	Norm T167	uno DI0MS0
T168	NC 997 1000	año
#168	Norm T168	año NCMS000
T169	RG 1001 1008	después
#169	Norm T169	después RG
T170	SP 1009 1011	de
#170	Norm T170	de SPS00
T171	DA 1012 1014	la
#171	Norm T171	el DA0FS0
T172	AO 1015 1022	primera
#172	Norm T172	1 AO0FS0
T173	NC 1023 1031	consulta
#173	Norm T173	consulta NCFS000
T174	DA 1032 1034	el
#174	Norm T174	el DA0MS0
T175	NC 1035 1043	paciente
#175	Norm T175	paciente NCCS000
T176	VM 1044 1051	refería
#176	Norm T176	referir VMII3S0
T177	NC 1052 1063	parestesias
#177	Norm T177	parestesia NCFP000
T178	SP 1064 1066	en
#178	Norm T178	en SPS00
T179	DA 1067 1070	las
#179	Norm T179	el DA0FP0
T180	NC 1071 1083	extremidades
#180	Norm T180	extremidad NCFP000
T181	AQ 1084 1094	inferiores
#181	Norm T181	inferior AQ0CP0
T182	Fc 1094 1095	,
#182	Norm T182	, Fc
T183	VM 1096 1105	asociadas
#183	Norm T183	asociar VMP00PF
T184	RG 1106 1116	nuevamente
#184	Norm T184	nuevamente RG
T185	SP 1117 1118	a
#185	Norm T185	a SPS00
T186	NC 1119 1128	petequias
#186	Norm T186	petequia NCFP000
T187	SP 1129 1131	en
#187	Norm T187	en SPS00
T188	NC 1132 1137	dicha
#188	Norm T188	dicha NCFS000
T189	NC 1138 1150	localización
#189	Norm T189	localización NCFS000
T190	Fc 1150 1151	,
#190	Norm T190	, Fc
T191	VM 1152 1163	presentando
#191	Norm T191	presentar VMG0000
T192	SP 1164 1166	en
#192	Norm T192	en SPS00
T193	DD 1167 1171	esta
#193	Norm T193	este DD0FS0
T194	NC 1172 1179	ocasión
#194	Norm T194	ocasión NCFS000
T195	NC 1180 1188	síndrome
#195	Norm T195	síndrome NCMS000
T196	AQ 1189 1198	nefrítico
#196	Norm T196	nefrítico AQ0MS0
T197	Fp 1198 1199	.
#197	Norm T197	. Fp
T198	SP 1200 1202	En
#198	Norm T198	en SPS00
T199	DA 1203 1205	la
#199	Norm T199	el DA0FS0
T200	NC 1206 1215	analítica
#200	Norm T200	analítica NCFS000
T201	VM 1216 1226	destacaban
#201	Norm T201	destacar VMII3P0
T202	Fd 1226 1227	:
#202	Norm T202	: Fd
T203	NC 1228 1246	hipocomplementemia
#203	Norm T203	hipocomplementemia NCFS000
T204	Fc 1246 1247	,
#204	Norm T204	, Fc
T205	NC 1248 1257	criocrito
#205	Norm T205	criocrito NCMS000
T206	SP 1258 1261	del
#206	Norm T206	de+el SPS00+DA0MS0
T207	Z 1262 1265	17%
#207	Norm T207	17% Z
T208	CC 1266 1267	y
#208	Norm T208	y CC
T209	NC 1268 1281	proteinograma
#209	Norm T209	proteinograma NCFS000
T210	SP 1282 1285	con
#210	Norm T210	con SPS00
T211	AQ 1286 1291	débil
#211	Norm T211	débil AQ0CS0
T212	NC 1292 1297	banda
#212	Norm T212	banda NCFS000
T213	AQ 1298 1305	anómala
#213	Norm T213	anómalo AQ0FS0
T214	SP 1306 1308	en
#214	Norm T214	en SPS00
T215	NC 1309 1313	zona
#215	Norm T215	zona NCFS000
T216	NC 1314 1319	gamma
#216	Norm T216	gamma NCFS000
T217	Fp 1319 1320	.
#217	Norm T217	. Fp
T218	NP 1321 1341	Inmunoelectroforesis
#218	Norm T218	inmunoelectroforesis NP00000
T219	AQ 1342 1348	sérica
#219	Norm T219	sérico AQ0FS0
T220	Fd 1348 1349	:
#220	Norm T220	: Fd
T221	NC 1350 1360	componente
#221	Norm T221	componente NCCS000
T222	SP 1361 1363	de
#222	Norm T222	de SPS00
T223	NC 1364 1373	movilidad
#223	Norm T223	movilidad NCFS000
T224	VM 1374 1385	restringida
#224	Norm T224	restringir VMP00SF
T225	NP 1386 1389	IgM
#225	Norm T225	igm NP00000
T226	NC 1390 1395	kappa
#226	Norm T226	kappa NCFS000
T227	Fpa 1396 1397	(
#227	Norm T227	( Fpa
T228	SP 1397 1399	en
#228	Norm T228	en SPS00
T229	DA 1400 1402	la
#229	Norm T229	el DA0FS0
T230	NC 1403 1408	orina
#230	Norm T230	orina NCFS000
T231	RN 1409 1411	no
#231	Norm T231	no RN
T232	VM 1412 1417	había
#232	Norm T232	haber VMII1S0
T233	DI 1418 1424	ningún
#233	Norm T233	ninguno DI0MS0
T234	NC 1425 1433	elemento
#234	Norm T234	elemento NCMS000
T235	AQ 1434 1444	sospechoso
#235	Norm T235	sospechoso AQ0MS0
T236	SP 1445 1447	de
#236	Norm T236	de SPS00
T237	NC 1448 1462	monoclonalidad
#237	Norm T237	monoclonalidad NCFS000
T238	Fpt 1462 1463	)
#238	Norm T238	) Fpt
T239	Fp 1463 1464	.
#239	Norm T239	. Fp
T240	DA 1465 1467	La
#240	Norm T240	el DA0FS0
T241	NC 1468 1475	función
#241	Norm T241	función NCFS000
T242	AQ 1476 1481	renal
#242	Norm T242	renal AQ0CS0
T243	VM 1482 1492	presentaba
#243	Norm T243	presentar VMII3S0
T244	DI 1493 1496	una
#244	Norm T244	uno DI0FS0
T245	NC 1497 1507	creatinina
#245	Norm T245	creatinina NCFS000
T246	SP 1508 1510	de
#246	Norm T246	de SPS00
T247	Z 1511 1514	1,2
#247	Norm T247	1.2 Z
T248	NC 1515 1517	mg
#248	Norm T248	mg NC00000
T249	Fh 1517 1518	/
#249	Norm T249	/ Fh
T250	NC 1518 1520	dl
#250	Norm T250	dl NC00000
T251	Fc 1520 1521	,
#251	Norm T251	, Fc
T252	NC 1522 1531	sedimento
#252	Norm T252	sedimento NCMS000
T253	SP 1532 1535	con
#253	Norm T253	con SPS00
T254	NC 1536 1544	hematíes
#254	Norm T254	hematíe NCMP000
T255	Fz 1545 1546	+
#255	Norm T255	+ Fz
T256	Fz 1546 1547	+
#256	Norm T256	+ Fz
T257	Fz 1547 1548	+
#257	Norm T257	+ Fz
T258	CC 1549 1550	y
#258	Norm T258	y CC
T259	NC 1551 1562	proteinuria
#259	Norm T259	proteinuria NCFS000
T260	SP 1563 1565	de
#260	Norm T260	de SPS00
T261	Z 1566 1569	2,8
#261	Norm T261	2.8 Z
T262	NC 1570 1571	g
#262	Norm T262	g NC00000
T263	Fh 1571 1572	/
#263	Norm T263	/ Fh
T264	NC 1572 1575	día
#264	Norm T264	día NCMS000
T265	Fp 1575 1576	.
#265	Norm T265	. Fp
T266	DA 1577 1579	La
#266	Norm T266	el DA0FS0
T267	NC 1580 1587	biopsia
#267	Norm T267	biopsia NCFS000
T268	AQ 1588 1593	renal
#268	Norm T268	renal AQ0CS0
T269	VM 1594 1602	confirmó
#269	Norm T269	confirmar VMIS3S0
T270	DA 1603 1605	la
#270	Norm T270	el DA0FS0
T271	NC 1606 1615	presencia
#271	Norm T271	presencia NCFS000
T272	SP 1616 1618	de
#272	Norm T272	de SPS00
T273	NC 1619 1636	glomerulonefritis
#273	Norm T273	glomerulonefritis NCFN000
T274	SP 1637 1640	con
#274	Norm T274	con SPS00
T275	NC 1641 1647	patrón
#275	Norm T275	patrón NCMS000
T276	AQ 1648 1663	mesangiocapilar
#276	Norm T276	mesangiocapilar AQ0CS0
T277	Fp 1663 1664	.
#277	Norm T277	. Fp
T278	P0 1665 1667	Se
#278	Norm T278	se P00CN000
T279	VM 1668 1674	añadió
#279	Norm T279	añadir VMIS3S0
T280	SP 1675 1677	al
#280	Norm T280	a+el SPS00+DA0MS0
T281	NC 1678 1689	tratamiento
#281	Norm T281	tratamiento NCMS000
T282	NC 1690 1701	azatioprina
#282	Norm T282	azatioprina NCFS000
T283	Fc 1701 1702	,
#283	Norm T283	, Fc
T284	SP 1703 1706	con
#284	Norm T284	con SPS00
T285	NC 1707 1720	mantenimiento
#285	Norm T285	mantenimiento NCMS000
T286	SP 1721 1723	de
#286	Norm T286	de SPS00
T287	DA 1724 1726	la
#287	Norm T287	el DA0FS0
T288	NC 1727 1734	función
#288	Norm T288	función NCFS000
T289	AQ 1735 1740	renal
#289	Norm T289	renal AQ0CS0
T290	CC 1741 1742	y
#290	Norm T290	y CC
T291	NC 1743 1755	proteinurias
#291	Norm T291	proteinuria NCFP000
T292	RG 1756 1765	alrededor
#292	Norm T292	alrededor RG
T293	SP 1766 1768	de
#293	Norm T293	de SPS00
T294	Z 1769 1770	1
#294	Norm T294	1 Z
T295	NC 1771 1772	g
#295	Norm T295	g NC00000
T296	Fp 1772 1773	.
#296	Norm T296	. Fp
T297	SP 1775 1779	Tras
#297	Norm T297	tras SPS00
T298	Z 1780 1784	seis
#298	Norm T298	6 Z
T299	NC 1785 1789	años
#299	Norm T299	año NCMP000
T300	SP 1790 1792	de
#300	Norm T300	de SPS00
T301	NC 1793 1804	seguimiento
#301	Norm T301	seguimiento NCMS000
T302	Fc 1804 1805	,
#302	Norm T302	, Fc
T303	P0 1806 1808	se
#303	Norm T303	se P00CN000
T304	VM 1809 1818	evidenció
#304	Norm T304	evidenciar VMIS3S0
T305	SP 1819 1821	en
#305	Norm T305	en SPS00
T306	DI 1822 1824	un
#306	Norm T306	uno DI0MS0
T307	NC 1825 1832	control
#307	Norm T307	control NCMS000
T308	AQ 1833 1842	analítico
#308	Norm T308	analítico AQ0MS0
T309	NC 1843 1857	inmunofenotipo
#309	Norm T309	inmunofenotipo NCMS000
T310	SP 1858 1860	de
#310	Norm T310	de SPS00
T311	NC 1861 1867	sangre
#311	Norm T311	sangre NCFS000
T312	AQ 1868 1878	periférica
#312	Norm T312	periférico AQ0FS0
T313	AQ 1879 1889	compatible
#313	Norm T313	compatible AQ0CS0
T314	SP 1890 1893	con
#314	Norm T314	con SPS00
T315	NC 1894 1897	LLP
#315	Norm T315	LLP NC00000
T316	Fp 1897 1898	.
#316	Norm T316	. Fp
T317	P0 1899 1901	Se
#317	Norm T317	se P00CN000
T318	VM 1902 1911	corroboró
#318	Norm T318	corroborar VMIS3S0
T319	RG 1912 1926	posteriormente
#319	Norm T319	posteriormente RG
T320	DD 1927 1931	este
#320	Norm T320	este DD0MS0
T321	NC 1932 1940	hallazgo
#321	Norm T321	hallazgo NCMS000
T322	SP 1941 1944	con
#322	Norm T322	con SPS00
T323	DI 1945 1947	un
#323	Norm T323	uno DI0MS0
T324	VM 1948 1956	aspirado
#324	Norm T324	aspirar VMP00SM
T325	SP 1957 1959	de
#325	Norm T325	de SPS00
T326	NC 1960 1966	médula
#326	Norm T326	médula NCFS000
T327	AQ 1967 1971	ósea
#327	Norm T327	óseo AQ0FS0
T328	SP 1972 1974	en
#328	Norm T328	en SPS00
T329	DA 1975 1977	el
#329	Norm T329	el DA0MS0
T330	PR 1978 1981	que
#330	Norm T330	que PR0CN000
T331	P0 1982 1984	se
#331	Norm T331	se P00CN000
T332	VM 1985 1992	observó
#332	Norm T332	observar VMIS3S0
T333	NC 1993 2005	infiltración
#333	Norm T333	infiltración NCFS000
T334	AQ 2006 2013	medular
#334	Norm T334	medular AQ0CS0
T335	SP 2014 2017	por
#335	Norm T335	por SPS00
T336	NC 2018 2026	síndrome
#336	Norm T336	síndrome NCMS000
T337	AQ 2027 2045	linfoproliferativo
#337	Norm T337	linfoproliferativo AQ0MS0
T338	AQ 2046 2053	crónico
#338	Norm T338	crónico AQ0MS0
T339	SP 2054 2056	de
#339	Norm T339	de SPS00
T340	NC 2057 2063	célula
#340	Norm T340	célula NCFS000
T341	AQ 2064 2071	pequeña
#341	Norm T341	pequeño AQ0FS0
T342	SP 2072 2074	de
#342	Norm T342	de SPS00
T343	AQ 2075 2080	línea
#343	Norm T343	líneo AQ0FS0
T344	NC 2081 2082	B
#344	Norm T344	B NC00000
T345	Fc 2082 2083	,
#345	Norm T345	, Fc
T346	AQ 2084 2094	compatible
#346	Norm T346	compatible AQ0CS0
T347	SP 2095 2098	con
#347	Norm T347	con SPS00
T348	NC 2099 2102	LLP
#348	Norm T348	LLP NC00000
T349	AQ 2103 2113	quiescente
#349	Norm T349	quiescente AQ0CS0
T350	Fc 2113 2114	,
#350	Norm T350	, Fc
T351	SP 2115 2118	por
#351	Norm T351	por SPS00
T352	DA 2119 2121	lo
#352	Norm T352	el DA0NS0
T353	PR 2122 2125	que
#353	Norm T353	que PR0CN000
T354	SP 2126 2128	en
#354	Norm T354	en SPS00
T355	DD 2129 2132	ese
#355	Norm T355	ese DD0MS0
T356	NC 2133 2140	momento
#356	Norm T356	momento NCMS000
T357	RN 2141 2143	no
#357	Norm T357	no RN
T358	VS 2144 2147	fue
#358	Norm T358	ser VSIS3S0
T359	AQ 2148 2158	tributario
#359	Norm T359	tributario AQ0MS0
T360	SP 2159 2161	de
#360	Norm T360	de SPS00
T361	NC 2162 2173	tratamiento
#361	Norm T361	tratamiento NCMS000
T362	SP 2174 2177	con
#362	Norm T362	con SPS00
T363	NC 2178 2191	quimioterapia
#363	Norm T363	quimioterapia NCFS000
T364	Fp 2191 2192	.
#364	Norm T364	. Fp
T365	DI 2193 2195	Un
#365	Norm T365	uno DI0MS0
T366	NC 2196 2199	año
#366	Norm T366	año NCMS000
T367	RG 2200 2203	más
#367	Norm T367	más RG
T368	RG 2204 2209	tarde
#368	Norm T368	tarde RG
T369	DA 2210 2212	el
#369	Norm T369	el DA0MS0
T370	NC 2213 2221	paciente
#370	Norm T370	paciente NCCS000
T371	VM 2222 2230	presenta
#371	Norm T371	presentar VMIP3S0
T372	NC 2231 2242	proteinuria
#372	Norm T372	proteinuria NCFS000
T373	AQ 2243 2254	persistente
#373	Norm T373	persistente AQ0CS0
T374	SP 2255 2257	de
#374	Norm T374	de SPS00
T375	Z 2258 2261	4,7
#375	Norm T375	4.7 Z
T376	NC 2262 2263	g
#376	Norm T376	g NC00000
T377	Fh 2263 2264	/
#377	Norm T377	/ Fh
T378	Z 2264 2266	24
#378	Norm T378	24 Z
T379	NC 2267 2268	h
#379	Norm T379	h NC00000
T380	Fc 2268 2269	,
#380	Norm T380	, Fc
T381	SP 2270 2273	por
#381	Norm T381	por SPS00
T382	DA 2274 2276	lo
#382	Norm T382	el DA0NS0
T383	PR 2277 2280	que
#383	Norm T383	que PR0CN000
T384	P0 2281 2283	se
#384	Norm T384	se P00CN000
T385	VM 2284 2290	decide
#385	Norm T385	decidir VMIP3S0
T386	VM 2291 2299	realizar
#386	Norm T386	realizar VMN0000
T387	DI 2300 2303	una
#387	Norm T387	uno DI0FS0
T388	AQ 2304 2309	nueva
#388	Norm T388	nuevo AQ0FS0
T389	NC 2310 2317	biopsia
#389	Norm T389	biopsia NCFS000
T390	AQ 2318 2323	renal
#390	Norm T390	renal AQ0CS0
T391	PR 2324 2327	que
#391	Norm T391	que PR0CN000
T392	VM 2328 2336	confirmó
#392	Norm T392	confirmar VMIS3S0
T393	DA 2337 2339	la
#393	Norm T393	el DA0FS0
T394	NC 2340 2349	presencia
#394	Norm T394	presencia NCFS000
T395	SP 2350 2352	de
#395	Norm T395	de SPS00
T396	DI 2353 2356	una
#396	Norm T396	uno DI0FS0
T397	NC 2357 2374	glomerulonefritis
#397	Norm T397	glomerulonefritis NCFN000
T398	AQ 2375 2392	crioglobulinémica
#398	Norm T398	crioglobulinémico AQ0FS0
T399	CC 2393 2394	y
#399	Norm T399	y CC
T400	VM 2395 2401	mostró
#400	Norm T400	mostrar VMIS3S0
T401	Fc 2401 2402	,
#401	Norm T401	, Fc
T402	RG 2403 2409	además
#402	Norm T402	además RG
T403	Fc 2409 2410	,
#403	Norm T403	, Fc
T404	NC 2411 2423	infiltración
#404	Norm T404	infiltración NCFS000
T405	AQ 2424 2436	linfocitaria
#405	Norm T405	linfocitario AQ0FS0
T406	AQ 2437 2447	compatible
#406	Norm T406	compatible AQ0CS0
T407	SP 2448 2451	con
#407	Norm T407	con SPS00
T408	NC 2452 2462	afectación
#408	Norm T408	afectación NCFS000
T409	SP 2463 2466	por
#409	Norm T409	por SPS00
T410	NC 2467 2474	linfoma
#410	Norm T410	linfoma NCMS000
T411	NC 2475 2476	B
#411	Norm T411	B NC00000
T412	SP 2477 2479	de
#412	Norm T412	de SPS00
T413	SP 2480 2484	bajo
#413	Norm T413	bajo SPS00
T414	NC 2485 2490	grado
#414	Norm T414	grado NCMS000
T415	Fp 2490 2491	.
#415	Norm T415	. Fp
T416	SP 2492 2496	Ante
#416	Norm T416	ante SPS00
T417	DA 2497 2499	la
#417	Norm T417	el DA0FS0
T418	NC 2500 2510	afectación
#418	Norm T418	afectación NCFS000
T419	AQ 2511 2516	renal
#419	Norm T419	renal AQ0CS0
T420	SP 2517 2520	por
#420	Norm T420	por SPS00
T421	DA 2521 2523	el
#421	Norm T421	el DA0MS0
T422	NC 2524 2531	linfoma
#422	Norm T422	linfoma NCMS000
T423	Fc 2531 2532	,
#423	Norm T423	, Fc
T424	P0 2533 2535	se
#424	Norm T424	se P00CN000
T425	VM 2536 2542	decide
#425	Norm T425	decidir VMIP3S0
T426	VM 2543 2550	iniciar
#426	Norm T426	iniciar VMN0000
T427	NC 2551 2562	tratamiento
#427	Norm T427	tratamiento NCMS000
T428	SP 2563 2566	con
#428	Norm T428	con SPS00
T429	NC 2567 2576	rituximab
#429	Norm T429	rituximab NCMS000
T430	SP 2577 2578	a
#430	Norm T430	a SPS00
T431	NC 2579 2584	dosis
#431	Norm T431	dosis NCFN000
T432	SP 2585 2587	de
#432	Norm T432	de SPS00
T433	Z 2588 2591	375
#433	Norm T433	375 Z
T434	NC 2592 2594	mg
#434	Norm T434	mg NC00000
T435	Fh 2594 2595	/
#435	Norm T435	/ Fh
T436	NC 2595 2597	m2
#436	Norm T436	m2 NC00000
T437	AQ 2598 2608	subcutáneo
#437	Norm T437	subcutáneo AQ0FP0
T438	Fpa 2609 2610	(
#438	Norm T438	( Fpa
T439	NC 2610 2614	s.c.
#439	Norm T439	s.c. NCFS000
T440	Fpt 2614 2615	)
#440	Norm T440	) Fpt
T441	SP 2616 2617	x
#441	Norm T441	x SPS00
T442	Z 2618 2619	4
#442	Norm T442	4 Z
T443	CC 2620 2621	y
#443	Norm T443	y CC
T444	NC 2622 2637	tandaderecambio
#444	Norm T444	tandaderecambio NCMS000
T445	AQ 2638 2648	plasmático
#445	Norm T445	plasmático AQ0MS0
T446	Fp 2648 2649	.
#446	Norm T446	. Fp
T447	SP 2651 2652	A
#447	Norm T447	A SPS00
T448	DA 2653 2656	los
#448	Norm T448	el DA0MP0
T449	Z 2657 2660	dos
#449	Norm T449	2 Z
T450	NC 2661 2665	años
#450	Norm T450	año NCMP000
T451	SP 2666 2668	de
#451	Norm T451	de SPS00
T452	VA 2669 2674	haber
#452	Norm T452	haber VAN0000
T453	VM 2675 2684	realizado
#453	Norm T453	realizar VMP00SM
T454	NC 2685 2696	tratamiento
#454	Norm T454	tratamiento NCMS000
T455	NC 2697 2706	anti-CD20
#455	Norm T455	anti-CD20 NC00000
T456	Fc 2706 2707	,
#456	Norm T456	, Fc
T457	DA 2708 2710	el
#457	Norm T457	el DA0MS0
T458	NC 2711 2719	paciente
#458	Norm T458	paciente NCCS000
T459	P0 2720 2722	se
#459	Norm T459	se P00CN000
T460	VM 2723 2732	encuentra
#460	Norm T460	encontrar VMIP3S0
T461	SP 2733 2736	con
#461	Norm T461	con SPS00
T462	NC 2737 2745	síndrome
#462	Norm T462	síndrome NCMS000
T463	AQ 2746 2764	linfoproliferativo
#463	Norm T463	linfoproliferativo AQ0MS0
T464	SP 2765 2767	en
#464	Norm T464	en SPS00
T465	NC 2768 2776	remisión
#465	Norm T465	remisión NCFS000
T466	CC 2777 2778	y
#466	Norm T466	y CC
T467	P0 2779 2781	se
#467	Norm T467	se P00CN000
T468	VM 2782 2790	mantiene
#468	Norm T468	mantener VMIP3S0
T469	DA 2791 2793	la
#469	Norm T469	el DA0FS0
T470	NC 2794 2804	afectación
#470	Norm T470	afectación NCFS000
T471	AQ 2805 2810	renal
#471	Norm T471	renal AQ0CS0
T472	SP 2811 2813	en
#472	Norm T472	en SPS00
T473	NC 2814 2819	forma
#473	Norm T473	forma NCFS000
T474	SP 2820 2822	de
#474	Norm T474	de SPS00
T475	NC 2823 2834	proteinuria
#475	Norm T475	proteinuria NCFS000
T476	AQ 2835 2843	residual
#476	Norm T476	residual AQ0CS0
T477	Fpa 2844 2845	(
#477	Norm T477	( Fpa
T478	Z 2845 2846	4
#478	Norm T478	4 Z
T479	NC 2847 2848	g
#479	Norm T479	g NC00000
T480	Fh 2848 2849	/
#480	Norm T480	/ Fh
T481	NC 2849 2852	día
#481	Norm T481	día NCMS000
T482	Fpt 2852 2853	)
#482	Norm T482	) Fpt
T483	SP 2854 2857	con
#483	Norm T483	con SPS00
T484	NC 2858 2865	función
#484	Norm T484	función NCFS000
T485	AQ 2866 2871	renal
#485	Norm T485	renal AQ0CS0
T486	VM 2872 2882	conservada
#486	Norm T486	conservar VMP00SF
T487	Fpa 2883 2884	(
#487	Norm T487	( Fpa
T488	NC 2884 2886	Cr
#488	Norm T488	cr NC00000
T489	Z 2887 2890	0,8
#489	Norm T489	0.8 Z
T490	NC 2891 2893	mg
#490	Norm T490	mg NC00000
T491	Fh 2893 2894	/
#491	Norm T491	/ Fh
T492	NC 2894 2896	dl
#492	Norm T492	dl NC00000
T493	Fc 2896 2897	,
#493	Norm T493	, Fc
T494	NC 2898 2900	FG
#494	Norm T494	FG NC00000
T495	Fd 2900 2901	:
#495	Norm T495	: Fd
T496	Z 2902 2905	100
#496	Norm T496	100 Z
T497	NC 2906 2908	ml
#497	Norm T497	ml NC00000
T498	Fh 2908 2909	/
#498	Norm T498	/ Fh
T499	NC 2909 2912	min
#499	Norm T499	min NC00000
T500	Fpt 2912 2913	)
#500	Norm T500	) Fpt
T501	SP 2914 2918	bajo
#501	Norm T501	bajo SPS00
T502	NC 2919 2930	tratamiento
#502	Norm T502	tratamiento NCMS000
T503	SP 2931 2934	con
#503	Norm T503	con SPS00
T504	AQ 2935 2940	doble
#504	Norm T504	doble AQ0CS0
T505	NC 2941 2948	bloqueo
#505	Norm T505	bloqueo NCMS000
T506	SP 2949 2952	del
#506	Norm T506	de+el SPS00+DA0MS0
T507	NC 2953 2956	eje
#507	Norm T507	eje NCMS000
T508	NC 2957 2988	renina-angiotensina-aldosterona
#508	Norm T508	renina-angiotensina-aldosterona NC00000
T509	Fp 2988 2989	.
#509	Norm T509	. Fp
